Haoxi Health Technology Limited and Global Mofy AI Ltd Announce Strategic Partnership to Innovate AI Marketing Solutions
September 25 2024 - 9:00AM
Haoxi Health Technology Limited (the “Company” or “HAO”), an online
marketing solution provider headquartered in Beijing, China, today
announced a strategic partnership with an AI platform, Gauss
Intelligence (Beijing) Technology Co., Ltd., a subsidiary of Global
Mofy AI Ltd (Nasdaq: GMM). This collaboration aims to leverage the
advanced capabilities of Gausspeed, a cutting-edge generative AI
platform, alongside HAO’s extensive application scenarios to
deliver transformative AI marketing solutions.
Through this partnership, Global Mofy will provide the powerful
AI capabilities of the Gausspeed platform, while HAO will
contribute its rich industry knowledge and practical application
expertise. Together, the two companies will focus on three key
areas: enhancing big data analysis, automating creative content
generation, and improving intelligent decision-making processes
that deliver optimal digital marketing solutions to the Company’s
vast client base.
Global Mofy is a leading digital asset bank in China, managing
over 100,000 digital assets. The company specializes in virtual
content and 3D asset development, with offices in Beijing,
Zhejiang, and California, aiming to enhance the digital content and
entertainment industries.
Gausspeed, launched in 2024 with Heartdub Technology, is an
advanced AI platform. It uses Gausspeed Physics AI to simulate
intelligent behavior and can build and navigate complex 3D
environments, allowing for precise object manipulation and virtual
city creation.
Gausspeed AI platform enables it to reason, plan, and execute
actions with unmatched accuracy, fostering sophisticated
interactions among digital assets. With Gausspeed, systems can
perceive and respond to their environments dynamically, creating
immersive experiences that are crucial for effective digital
marketing.
“Partnering with Global Mofy represents a pivotal opportunity
for us,” said Mr. Zhen Fan, CEO and Chairman of the Company. “By
integrating the robust AI capabilities of the Gausspeed platform
with our experience in marketing solutions, we are set to
revolutionize how digital marketing is approached in our
industry.”
“The collaboration allows us to apply Gausspeed’s innovative
technology in impactful ways, driving digital transformation across
the marketing landscape. As AI technology continues to evolve, the
collaboration between HAO and Global Mofy is poised to invigorate
the industry, fostering innovation and transformation in digital
marketing.”
About Haoxi Health Technology Limited
Haoxi Health Technology Limited is a Beijing-headquartered
online marketing solution provider in China, specializing in
serving healthcare industry advertiser clients. The Company’s
growth is driven by the rise of news feed ads and the rapid
development of the healthcare sector. The Company offers one-stop
online marketing solutions, especially in online short video
marketing, helping advertisers acquire and retain customers on
popular platforms in China, such as Toutiao, Douyin, WeChat, and
Sina Weibo. It is dedicated to reducing costs, increasing
efficiency, and providing easy online marketing solutions to
advertisers. For more information, please visit:
http://ir.haoximedia.com.
Forward-Looking Statement
This press release contains forward-looking statements.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events or performance, and
underlying assumptions and other statements that are other than
statements of historical facts. When the Company uses words such as
“may,” “will,” “intend,” “should,” “believe,” “expect,”
“anticipate,” “project,” “estimate” or similar expressions that do
not relate solely to historical matters, it is making
forward-looking statements. Forward-looking statements are not
guarantees of future performance and involve risks and
uncertainties that may cause the actual results to differ
materially from the Company’s expectations discussed in the
forward-looking statements. These statements are subject to
uncertainties and risks including, but not limited to, the
uncertainties related to market conditions, and other factors
discussed in the “Risk Factors” section of the registration
statement filed with the SEC. For these reasons, among others,
investors are cautioned not to place undue reliance upon any
forward-looking statements in this press release. Additional
factors are discussed in the Company’s filings with the SEC, which
are available for review at www.sec.gov. The Company undertakes no
obligation to publicly revise these forward-looking statements to
reflect events or circumstances that arise after the date
hereof.
For more information, please contact:Investor
RelationsWFS Investor Relations Inc.Janice Wang, Managing
PartnerEmail: services@wealthfsllc.comPhone: +86 13811768599+1 628
283 9214
Haoxi Health Technology (NASDAQ:HAO)
Historical Stock Chart
From Oct 2024 to Nov 2024
Haoxi Health Technology (NASDAQ:HAO)
Historical Stock Chart
From Nov 2023 to Nov 2024